USD 0.17
(8.57%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 8.15 Million USD | 2.05% |
2022 | 7.98 Million USD | 61.16% |
2021 | 4.95 Million USD | 133.4% |
2020 | 2.12 Million USD | 109.43% |
2019 | 1.01 Million USD | -6.89% |
2018 | 1.08 Million USD | 66.77% |
2017 | 653 Thousand USD | 0.0% |
2014 | 366.44 Thousand USD | 246.71% |
2013 | 105.69 Thousand USD | -82.25% |
2012 | 595.5 Thousand USD | 35.92% |
2011 | 438.12 Thousand USD | 165.32% |
2010 | 165.13 Thousand USD | -52.42% |
2009 | 347.09 Thousand USD | -41.04% |
2008 | 588.69 Thousand USD | -37.49% |
2007 | 941.75 Thousand USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 3.08 Million USD | 13.39% |
2024 Q1 | 2.72 Million USD | 11.15% |
2023 FY | 8.15 Million USD | 2.05% |
2023 Q3 | 2 Million USD | 8.01% |
2023 Q4 | 2.45 Million USD | 22.21% |
2023 Q2 | 1.85 Million USD | 0.86% |
2023 Q1 | 1.84 Million USD | -9.97% |
2022 Q2 | 2.01 Million USD | -1.6% |
2022 Q1 | 2.04 Million USD | 7.23% |
2022 FY | 7.98 Million USD | 61.16% |
2022 Q4 | 2.04 Million USD | 8.22% |
2022 Q3 | 1.88 Million USD | -6.09% |
2021 Q2 | 981.37 Thousand USD | 39.4% |
2021 Q1 | 704 Thousand USD | 14.36% |
2021 FY | 4.95 Million USD | 133.4% |
2021 Q4 | 1.9 Million USD | 39.63% |
2021 Q3 | 1.36 Million USD | 39.1% |
2020 Q4 | 615.58 Thousand USD | 16.15% |
2020 Q2 | 472 Thousand USD | -6.72% |
2020 FY | 2.12 Million USD | 109.43% |
2020 Q1 | 506 Thousand USD | 148.04% |
2020 Q3 | 530 Thousand USD | 12.29% |
2019 Q1 | 280 Thousand USD | 42.86% |
2019 Q3 | 225 Thousand USD | -26.23% |
2019 Q4 | 204 Thousand USD | -9.33% |
2019 FY | 1.01 Million USD | -6.89% |
2019 Q2 | 305 Thousand USD | 8.93% |
2018 Q1 | 351 Thousand USD | 172.09% |
2018 Q4 | 196 Thousand USD | -27.68% |
2018 Q3 | 271 Thousand USD | -0.37% |
2018 Q2 | 272 Thousand USD | -22.51% |
2018 FY | 1.08 Million USD | 66.77% |
2017 Q4 | 129 Thousand USD | 13.16% |
2017 Q2 | 170 Thousand USD | -3.95% |
2017 Q1 | 177 Thousand USD | 0.0% |
2017 FY | 653 Thousand USD | 0.0% |
2017 Q3 | 114 Thousand USD | -32.94% |
2015 Q1 | 160.85 Thousand USD | 61.97% |
2014 FY | 366.44 Thousand USD | 246.71% |
2014 Q2 | -611.03 Thousand USD | -248.29% |
2014 Q1 | 412.04 Thousand USD | 7.83% |
2014 Q4 | 99.3 Thousand USD | -31.8% |
2014 Q3 | 145.61 Thousand USD | 123.83% |
2013 Q3 | 183.32 Thousand USD | 358.24% |
2013 Q4 | 382.11 Thousand USD | 108.43% |
2013 FY | 105.69 Thousand USD | -82.25% |
2013 Q1 | 36.33 Thousand USD | 92.73% |
2013 Q2 | 40 Thousand USD | 10.11% |
2012 Q3 | 10.5 Thousand USD | 125.13% |
2012 Q4 | 18.85 Thousand USD | 79.54% |
2012 FY | 595.5 Thousand USD | 35.92% |
2012 Q1 | 284.94 Thousand USD | 75.11% |
2012 Q2 | -41.78 Thousand USD | -114.67% |
2011 Q3 | 189.22 Thousand USD | 540.18% |
2011 Q1 | 136.47 Thousand USD | -53.9% |
2011 Q4 | 162.72 Thousand USD | -14.0% |
2011 Q2 | -42.98 Thousand USD | -131.5% |
2011 FY | 438.12 Thousand USD | 165.32% |
2010 FY | 165.13 Thousand USD | -52.42% |
2010 Q2 | 28.34 Thousand USD | 427.66% |
2010 Q1 | 5372.00 USD | -91.81% |
2010 Q4 | 296.03 Thousand USD | 509.16% |
2010 Q3 | 48.59 Thousand USD | 71.44% |
2009 Q4 | 65.58 Thousand USD | -0.38% |
2009 FY | 347.09 Thousand USD | -41.04% |
2009 Q3 | 65.83 Thousand USD | 22.18% |
2009 Q2 | 53.87 Thousand USD | -59.09% |
2009 Q1 | 131.7 Thousand USD | 66.4% |
2008 Q4 | 79.15 Thousand USD | 2.91% |
2008 Q3 | 76.91 Thousand USD | -36.11% |
2008 Q1 | 160.74 Thousand USD | -66.11% |
2008 Q2 | 120.38 Thousand USD | -25.11% |
2008 FY | 588.69 Thousand USD | -37.49% |
2007 Q2 | 9694.00 USD | -97.19% |
2007 Q3 | 166.71 Thousand USD | 1619.8% |
2007 FY | 941.75 Thousand USD | 0.0% |
2007 Q4 | 474.28 Thousand USD | 184.48% |
2007 Q1 | 345.53 Thousand USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Achiko AG | 62.5 Thousand USD | -12941.077% |
Accelera Innovations, Inc | - USD | -Infinity% |
Aspyra Inc. | 8.52 Million USD | 4.392% |
Cannabis Sativa, Inc. | 1.17 Million USD | -594.443% |
CompuMed, Inc. | 5.83 Million USD | -39.627% |
CompuGroup Medical SE & Co. KGaA | 1.31 Billion USD | 99.378% |
Cogstate Limited | 43.42 Million USD | 81.23% |
CareView Communications, Inc. | 9.68 Million USD | 15.83% |
Craneware plc | 189.26 Million USD | 95.693% |
Caduceus Software Systems Corp. | 6.58 Million USD | -23.728% |
Certive Solutions Inc. | 1.27 Million USD | -541.668% |
Drug Free Solution, Inc. | 805.00 USD | -1012519.379% |
DATATRAK International, Inc. | 6.18 Million USD | -31.812% |
Strainsforpains, Inc. | 84.11 Thousand USD | -9590.886% |
Healixa Inc. | 598.88 Thousand USD | -1261.127% |
Easy Technologies Inc. | - USD | -Infinity% |
eWellness Healthcare Corporation | - USD | -Infinity% |
Founders Bay Holdings | 16.45 Million USD | 50.473% |
Health Discovery Corporation | - USD | -Infinity% |
Healthcare Integrated Technologies, Inc. | 322 Thousand USD | -2431.548% |
H-Source Holdings Ltd. | - USD | -Infinity% |
InterCare DX, Inc. | - USD | -Infinity% |
IQ-AI Limited | 775.75 Thousand USD | -950.797% |
Cannabiz Mobile, Inc. | - USD | -Infinity% |
Mednow Inc. | 12.99 Million USD | 37.278% |
Galileo Life Sciences, Inc. | - USD | -Infinity% |
MediXall Group, Inc. | 59.26 Thousand USD | -13653.773% |
Mitesco, Inc. | - USD | -Infinity% |
MobileSmith, Inc. | 1.57 Million USD | -418.257% |
NantHealth, Inc. | 67 Million USD | 87.834% |
Net Medical Xpress Solutions, Inc. | 597 Thousand USD | -1265.425% |
OneLife Technologies Corp. | - USD | -Infinity% |
ORHub, Inc. | 324.86 Thousand USD | -2409.192% |
Patient Access Solutions, Inc. | 212.73 Thousand USD | -3731.785% |
Pharma-Bio Serv, Inc. | 16.97 Million USD | 51.984% |
PPJ Healthcare Enterprises, Inc. | 711.03 Thousand USD | -1046.433% |
Medical Cannabis Payment Solutions, Inc. | - USD | -Infinity% |
Renalytix Plc | 2.28 Million USD | -256.12% |
Revium Recovery Inc. | - USD | -Infinity% |
RYAH Group, Inc. | - USD | -Infinity% |
Carepay Inc. | 1.46 Million USD | -456.669% |
Vaso Corporation | 81.02 Million USD | 89.939% |
Vynleads, Inc. | - USD | -Infinity% |